Clearside Biomedical Inc (CLSD) — Capital Reinvestment Ratio

Latest as of December 2023: 0.24x

Clearside Biomedical Inc (CLSD) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow ($495.00K) in capital expenditures ($120.00K). Check CLSD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x

Capex / Operating Cash Flow

Operating Cash Flow

$495.00K

USD

Capital Expenditures

$120.00K

USD

Data as of

Dec 2023

Most recent filing

Annual Capital Reinvestment Ratio for Clearside Biomedical Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Clearside Biomedical Inc from None to None. See CLSD free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow